Overview
OpenBCI makes open-source brain-computer interface hardware and software, including the Cyton, Ganglion, and Ultracortex headsets, designed to democratize access to EEG and biopotential sensing for researchers, developers, and makers. Their open ecosystem has fostered a broad community of BCI innovation worldwide.
OpenBCI is a New York-based neurotechnology company that develops open-source brain-computer interface hardware and software for researchers, developers, and makers worldwide. The company's flagship products include the Cyton and Ganglion biosensing boards, which enable affordable, high-quality EEG and biopotential signal acquisition, as well as the Ultracortex headset, a customizable 3D-printable EEG headset designed for flexible research applications. Their software platform, OpenBCI GUI, provides accessible tools for real-time data visualization and analysis, lowering the technical barriers that have historically limited BCI experimentation. By releasing their designs and code under open-source licenses, OpenBCI has made professional-grade neural sensing technology available at a fraction of the cost of traditional research systems.
Operating as a bootstrapped company, OpenBCI has achieved significant reach without external venture funding, building a global user base that spans academic institutions, independent researchers, and the broader maker community. Their products have been adopted in university laboratories, rehabilitation research settings, and creative technology projects across dozens of countries, demonstrating strong organic demand for accessible neurotechnology tools. The company has cultivated an active open-source community that continuously contributes new applications, integrations, and research findings built on the OpenBCI platform. This community-driven model has allowed the company to expand its ecosystem far beyond what its internal team alone could produce.
OpenBCI occupies a distinctive and important role in the neurotechnology industry by democratizing access to tools that were once confined to well-funded academic and corporate laboratories. By reducing cost and complexity barriers, the company has accelerated grassroots BCI research and helped train a new generation of neurotechnology practitioners and engineers. Their open ecosystem has enabled a diversity of experimental approaches that would be difficult to pursue within closed, proprietary research frameworks. In an industry often characterized by high costs and limited transparency, OpenBCI's model represents a meaningful counterforce that broadens participation and drives innovation across the entire field.
More in Research Tools
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🔭 Research Tools
Location
New York, USA
Funding
Bootstrapped
Website
www.openbci.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →